FELADILIMAB
UNII OUP4QB2A3R

Substance Identification & Data

This profile provides standardized clinical and technical data for Feladilimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) OUP4QB2A3R.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2252518-85-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

OUP4QB2A3R

CAS Registry Number

2252518-85-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

FELADILIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C126804

National Cancer Institute reference terminology for clinical and research data.

INN ID

11311

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-30

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Feladilimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FELADILIMAB

Common Names & Synonyms

ANTI-ICOS AGONIST ANTIBODY GSK3359609

FELADILIMAB [INN]

FELADILIMAB [JAN]

FELADILIMAB [USAN]

FELADILIMAB [WHO-DD]

HUMANISED IGG4 KAPPA ANTI-ICOS AGONIST MONOCLONAL ANTIBODY RECOMBINANT EX-CHO GSK3359609

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS INDUCIBLE T-CELL COSTIMULATOR (ACTIVATION-INDUCIBLE LYMPHOCYTE IMMUNOMEDIATORY MOLECULE; CD278 ANTIGEN)); HUMANIZED MONOCLONAL ANTIBODY; .GAMMA.4 HEAVY CHAIN HUMANIZED (1-448) (VH (HOMO SAPIENS IGHV1-69*06 (85%) (IGHD)-IGHJ3*01 (93%)) (8.9.14) (1-121)-HOMO SAPIENS IGHG4*01 (HINGE(S10>P(229)), CH2(L5>E(236))) (122-448)) (135-213')-DISULFIDE WITH .KAPPA. LIGHT CHAIN HUMANIZED (1'-213') (V-KAPPA (HOMO SAPIENS IGKV3-11*01 (85%) IGKJ2*01)(5.3.9) (1'-106')-HOMO SAPIENS IGKC*01 (107'-213')), DIMER (227-227'':230-230'')-BISDISULFIDE

Systematic Nomenclature

IMMUNOGLOBULIN G4 (229-PROLINE,236-GLUTAMIC ACID), ANTI-(HUMAN INDUCIBLE T-CELL CO-STIMULATOR (ICOS)) (HUMAN-MUS MUSCULUS MONOCLONAL GSK3359609 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GSK3359609 .KAPPA.-CHAIN, DIMER

SYS